BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chwiesko A, Kowal-Bielecka O, Sierakowski S. Perspectives on the interlinked nature of systemic sclerosis and reflux disease. Expert Rev Gastroenterol Hepatol. 2019;13:213-227. [PMID: 30791766 DOI: 10.1080/17474124.2019.1561274] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Lechien JR. Treating and Managing Laryngopharyngeal Reflux Disease in the Over 65s: Evidence to Date. CIA 2022;Volume 17:1625-1633. [DOI: 10.2147/cia.s371992] [Reference Citation Analysis]
2 Frieling T. Sklerodermie. Gastroenterologie 2022;17:296-307. [DOI: 10.1007/s11377-022-00646-3] [Reference Citation Analysis]
3 Hui M, Wang X, Zhou J, Zhang L, Duan X, Li M, Wang Q, Zhao J, Hou Y, Xu D, Zeng X. Systemic sclerosis patients with negative antinuclear antibodies have distinctive clinical manifestations: a multicenter CRDC cohort in China. Z Rheumatol. [DOI: 10.1007/s00393-022-01242-0] [Reference Citation Analysis]
4 Cheah JX, Khanna D, Mcmahan ZH. Management of scleroderma gastrointestinal disease: Lights and shadows. Journal of Scleroderma and Related Disorders. [DOI: 10.1177/23971983221086343] [Reference Citation Analysis]
5 Li B, Yan J, Pu J, Tang J, Xu S, Wang X. Esophageal Dysfunction in Systemic Sclerosis: An Update. Rheumatol Ther 2021;8:1535-49. [PMID: 34628599 DOI: 10.1007/s40744-021-00382-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Luquez-Mindiola A, Atuesta AJ, Gómez-Aldana AJ. Gastrointestinal manifestations of systemic sclerosis: An updated review. World J Clin Cases 2021; 9(22): 6201-6217 [PMID: 34434988 DOI: 10.12998/wjcc.v9.i22.6201] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Fedorov IA, Rybakova OG, Goreva EA. Microaspiration in GER as one of the causes of bronchial asthma exacerbation and the occurrence of chronic cough in children. History of the problem and diagnostics. jour 2021;20:97-102. [DOI: 10.52420/2071-5943-2021-20-1-97-102] [Reference Citation Analysis]
8 Roofeh D, Lescoat A, Khanna D. Treatment for systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol 2021;33:240-8. [PMID: 33741803 DOI: 10.1097/BOR.0000000000000795] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
9 Nihtyanova SI, Denton CP. Pathogenesis of systemic sclerosis associated interstitial lung disease. Journal of Scleroderma and Related Disorders 2020;5:6-16. [DOI: 10.1177/2397198320903867] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]